RQX PHARMACEUTICALS, INC.

Profile

Company Names

RQX PHARMACEUTICALS, INC.

Addresses

11099 N. TORREY PINES ROAD, SUITE 290, LA JOLLA, CA 92037

Phone Numbers

(858) 768-7826

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$2,216,716.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2011-02-01 
$1,191,716.00 
$7,000,050.00 
$5,808,334.00 
Equity 
1
2010-11-19 
$1,025,000.00 
$7,000,000.00 
$5,975,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
THOMAS 
A. 
COLL 
EXECUTIVE OFFICER
RQX PHARMACEUTICALS, INC.
DOUGLAS 
 
DOWNS 
EXECUTIVE OFFICER
REVISION THERAPEUTICS, INC.   |  OTONOMY, INC.   |  AVALON VENTURES IX, L.P.   |  RQX PHARMACEUTICALS, INC.   |  AFRAXIS, INC.   |  AVALON VENTURES X, L.P.   |  PROXIMAL DATA, INC.   |  SYNTHORX, INC.   |  ARISTAMD, INC.   |  ANKASA REGENERATIVE THERAPEUTICS, INC.   |  CARBON ROBOTICS INC.   |  DEEPOW CAPITAL OPPORTUNITY FUND I, LP
JAY 
 
LITCHER 
DIRECTOR
RQX PHARMACEUTICALS, INC.
FLOYD 
 
ROMESBERG 
DIRECTOR
RQX PHARMACEUTICALS, INC.   |  SYNTHORX, INC.
COURT 
R. 
TURNER 
EXECUTIVE OFFICER, DIRECTOR
RQX PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-02-17
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-01 
2010-12-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#